title: Management of multinodular goiter in Germany (Papillon 2005): do the approaches of thyroid specialists and primary care practitioners differ?
abstract: OBJECTIVE
  Large-scale survey to focus on management of multinodular goiter and to compare the approaches of practitioners in primary care and thyroid specialists in Germany.
  
  
  METHODS
  Replies to a questionnaire were received from 2,191 practitioners and 297 thyroid specialists between June 1 and September 30, 2005. The hypothetical cases and their modifications described multinodular goiters of different sizes with and without toxic nodules.
  
  
  RESULTS
  In the workup, TSH determination and thyroid sonography were found to be standard procedures. Scintigraphy was selected by 80.2% of practitioners and 92.9% of specialists (p < 0.001), in preference to fine needle aspiration cytology (17.9% of practitioners and 34.5% of the specialists, p < 0.001). Only 6.1% of practitioners and 24.4% of specialists (p < 0.001) advocated calcitonin screening. Euthyroid multinodular goiter (50-80 ml) was treated medically by 67.1% of practitioners and 65.6% of specialists, the combination of levothyroxine with iodine being clearly preferred (54.5% of practitioners, 52.3% of specialists). For toxic nodular goiter the preference for radioiodine therapy was significantly higher (p < 0.001) among specialists (67.7%) than among practitioners (47.5%). Referral to surgery was recommended for cold nodules with negative cytology by 64.9% of practitioners and 73.5% of specialists (p = 0.004).
  
  
  CONCLUSIONS
  Treatment and diagnostic procedures are used to nearly the same extent in primary care and specialist institutions, but the opinions diverge over the issues of calcitonin screening and referral for radioiodine therapy.
authors.affiliation: Department of Nuclear Medicine, University of Cologne, Kerpener Str. 62, 50937 Cologne, Germany. markus.dietlein@uni-koeln.de
authors.forename: M
authors.initials: M
authors.lastname: Dietlein
authors.forename: K
authors.initials: K
authors.lastname: Wegscheider
authors.forename: R
authors.initials: R
authors.lastname: Vaupel
authors.forename: M
authors.initials: M
authors.lastname: Schmidt
authors.forename: H
authors.initials: H
authors.lastname: Schicha
mesh_terms: D002116:Calcitonin / Q000097:blood; D003131:Combined Modality Therapy; D005194:Family Practice; D005858:Germany; D006044:Goiter, Nodular / Q000000981:diagnostic imaging / Q000628:therapy*; D006306:Health Surveys; D006801:Humans; D007388:Internal Medicine; D010821:Physicians, Family; D011336:Probability; D011877:Radionuclide Imaging; D011795:Surveys and Questionnaires; D013964:Thyroid Neoplasms / Q000453:epidemiology; D013965:Thyroidectomy; D013974:Thyroxine / Q000627:therapeutic use; D014463:Ultrasonography
chemical_list: D002116:Calcitonin; D013974:Thyroxine